TransDigm Group Incorporated TDG 深 沪
等待开盘 04-03 09:30:00 美东时间
1167.28
-5.990
-0.51%
华盛通- 最 高1175.34
- 今 开1166.63
- 成交量 26.26万股
- 最 低 1145.06
- 昨 收 1173.27
- 总市值 659.20亿
- 52周最高 1533.825
- 市盈率 静 36.41
- 换手率 0.47%
- 52周最低 1123.61
- 委 比 28.57%
- 总股本 5647.36万
- 历史最高 1533.825
- 量 比 0.53
- 振 幅 2.58%
- 历史最低 -278.24
- 每 手 1
- 风险率 76.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后爆锤！耐克遭10家大行集体下调目标价；NCNO、RH、艾默生电气等也遭大行下调目标价
今日重点评级关注：Canaccord Genuity：维持Generac控股"买入"评级，目标价从275美元升至300美元；Oppenheimer：维持Biogen"跑赢大市"评级，目标价从250美元升至275美元
04-02 16:17
Wells Fargo Initiates Coverage On TransDigm Group with Equal-Weight Rating, Announces Price Target of $1200
Wells Fargo analyst David Strauss initiates coverage on TransDigm Group (NYSE:TDG) with a Equal-Weight rating and announces Price Target of $1200.
04-01 23:19
TransDigm Co-Chief Operating Officer Joel Reiss Disposes of Common Shares
TransDigm Co-Chief Operating Officer Joel Reiss Disposes of Common Shares Joel Reiss, Co-Chief Operating Officer of TransDigm Group Incorporated, reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Pub
02-19 05:01
TransDigm Group kündigt neues Schuldenangebot im Gesamtwert von 2 Milliarden US-Dollar an
TransDigm Group kündigt neues Schuldenangebot im Gesamtwert von 2 Milliarden US-Dollar an TransDigm Group Incorporated hat angekündigt, dass ihre hundertprozentige Tochtergesellschaft TransDigm Inc., vorbehaltlich der Markt- und anderer Bedingungen, ein Schuldenangebot in Höhe von insgesamt 2 Millia
02-09 22:20
A Look Into TransDigm Group Inc's Price Over Earnings
In the current market session, TransDigm Group Inc. (NYSE:TDG) price is at $127...
02-07 03:00
Keybanc Downgrades TransDigm Group to Sector Weight
Keybanc analyst Michael Leshock downgrades TransDigm Group (NYSE:TDG) from Overweight to Sector Weight.
02-05 20:03
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
UBS Maintains Buy on TransDigm Group, Lowers Price Target to $1800
UBS analyst Gavin Parsons maintains TransDigm Group (NYSE:TDG) with a Buy and lowers the price target from $1804 to $1800.
02-05 02:44
TransDigm downgraded at Baird, citing margin pressure and leverage risks
Baird Equity Research on Wednesday downgraded TransDigm Group Inc. (TDG) to Neutral from a previous investment rating of Outperform, arguing that a shift in business mix toward lower-margin original e...
02-05 01:44
财报速睇 | TransDigm Group Incorporated 2025财年Q4营收22.85亿美元，同比增长13.9%；归母净利润3.86亿美元，同比下滑13.1%
华盛资讯2月4日讯，TransDigm Group Incorporated公布2025财年Q4业绩，公司Q4营收22.85亿美元，同比增长13.9%，归母净利润3.86亿美元，同比下滑13.1%。
02-04 22:17
